U.S., Aug. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07746050) titled 'Value of Biomarkers of Brain Injury for Predicting Psycho-cognitive Sequelae Secondary to Sepsis: a Prospective Multicenter Study' on March 26.
Brief Summary: To evaluate the value of biomarkers of neuronal and glial injury for predicting cognitive impairment (memory impairment assessed by a MoCA score < 26/30) at 3 months in patient admitted in the intensive care unit for a sepsis or a septic shock.
Study Start Date: Sept., 2026
Study Type: INTERVENTIONAL
Condition:
Sepsis
Septic Shock
Intervention:
BIOLOGICAL: Serum
Neurofilament light chain NfL, brain-derived tau, GFAP, UCHL1, p-tau217, s100B, neurone specific enolase NSE, ...